Zinzino group revenue increased with a total of 32 %, compared with the previous year. GOTHENBURG, Sweden, March 4, 2026 /PRNewswire/ — The revenue in February for Zinzino’s sales markets increased by 32 % and amounted to SEK 281.1 (212.7) million. Faun Pharma’s external sales increased and amounted to SEK 5.2 (4.2) million. Overall, the Group increased revenues by 32 % to SEK 286.3 (216.9) million compared with the previous year.Accumulated revenue for January – February 2026 increased by 26 % to SEK 568.6 (450.8) million.Revenues were distributed as follows:
Countries in regions:-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden-Central Europe: Austria, Germany, Switzerland-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands-The Baltics: Estonia, Latvia, Lithuania-North America: Canada, USA, Mexico-South America: Peru, Colombia-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea-Africa: South AfricaFor more information:Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, [email protected]
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, [email protected]Pictures for publication free of charge: [email protected]Certified Adviser: Tapper Partners ABThis information was brought to you by Cision http://news.cision.comhttps://news.cision.com/zinzino/r/zinzino-ab–publ–preliminary-sales-report-february-2026,c4316236The following files are available for download:
Regions,MSEK | 26-Feb | 25-Feb | Change | YTD 2026 | YTD 2025 | Change |
The Nordics | 22.5 | 24.8 | -9 % | 50.1 | 50.5 | -1 % |
Central Europe | 81.8 | 57.4 | 43 % | 171.0 | 126.8 | 35 % |
East Europe | 26.2 | 29.0 | -10 % | 55.9 | 63.2 | -12 % |
South & West Europe | 50.2 | 37.8 | 33 % | 97.2 | 82.0 | 19 % |
The Baltics | 8.5 | 8.8 | -3 % | 18.9 | 19.3 | -2 % |
North America | 67.5 | 32.5 | 108 % | 109.9 | 53.8 | 104 % |
South America | 3.6 | 1.2 | 200 % | 7.5 | 2.1 | 257 % |
Asia-Pacific | 18.6 | 19.7 | -6 % | 41.7 | 41.2 | 1 % |
Africa | 2.2 | 1.5 | 47 % | 4.1 | 3.0 | 37 % |
Zinzino | 281.1 | 212.7 | 32 % | 556.3 | 441.9 | 26 % |
Faun Pharma | 5.2 | 4.2 | 24 % | 12.3 | 8.9 | 38 % |
Zinzino Group | 286.3 | 216.9 | 32 % | 568.6 | 450.8 | 26 % |
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, [email protected]Pictures for publication free of charge: [email protected]Certified Adviser: Tapper Partners ABThis information was brought to you by Cision http://news.cision.comhttps://news.cision.com/zinzino/r/zinzino-ab–publ–preliminary-sales-report-february-2026,c4316236The following files are available for download:
Source link
Leave a Reply